Stocks
AstraZeneca PLCAZN
NYSEHealthcarePharmaceuticals$189.90-1.35%
A global biopharmaceutical company focused on the development and commercialization of prescription medicines, with core franchises in oncology, cardiovascular, renal and metabolism, respiratory, immunology, and rare diseases. Revenue is driven by a portfolio of blockbuster therapies and an extensive late-stage pipeline, making clinical trial data, regulatory approvals, and patent expirations key catalysts for investors. With a significant international footprint and exposure to pricing and reimbursement trends, it is closely watched for pipeline execution and capital allocation decisions.
Market Cap: $294.4B52W Range: $122.48 – $212.71
Congressional Interest in AstraZeneca PLC (AZN)
15 members of Congress have disclosed 50 trades in AstraZeneca PLC (AZN), a Healthcare company. The buy/sell breakdown shows 28 purchases versus 22 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
15
Buys
28
Sells
22
Who in Congress Is Trading AZN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-09-08 | Shelley M Capito | buy | $1K – $15K |
| 2017-07-11 | John Rutherford | buy | $1K – $15K |